Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: Comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils

Immunobiology

Volumn 213, Issue 2, 2008, Pages 109-124

  Kolaczkowska, Elzbieta ^a   Arnold, Bernd ^b   Opdenakker, Ghislain ^c  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Mast cells; Matrix metalloproteinase; Monocytes macrophages; Neutrophils; Peritoneal inflammation

Indexed keywords

GELATINASE B; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; IMMUNE RESPONSE; INFLAMMATION; MALE; MAST CELL; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PERITONITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 38549115153     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.07.005     Document Type: Article

References (55)

1. Ajuebor M.N., Das A.M., Virag L., Flower R.J., Szabo C., and Perretti M. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J. Immunol. 162 (1999) 1685-1691
2. Baram D., Vaday G.G., Salamon P., Drucker I., Hershkoviz R., and Mekori Y.A. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J. Immunol. 167 (2001) 4008-4016
3. Bottcher T., Spreer A., Azeh I., Nau R., and Gerber J. Matrix metalloproteinase-9 deficiency impairs host defense mechanisms against Streptococcus pneumoniae in a mouse model of bacterial meningitis. Neurosci. Lett. 338 (2003) 201-204
4. Chadzinska M., Maj M., Scislowska-Czarnecka A., Przewlocka B., and Plytycz B. Expression of proenkephalin (PENK) mRNA in inflammatory leukocytes during experimental peritonitis in Swiss mice. Pol. J. Pharmacol. 53 (2001) 715-718
5. Chakrabarti S., and Patel K.D. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J. Leukoc. Biol. 78 (2005) 279-288
6. Chakrabarti S., Zee J.M., and Patel K.D. Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release. J. Leukoc. Biol. 79 (2006) 214-222
7. Cowland J.B., and Borregaard N. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J. Leukoc. Biol. 66 (1999) 989-995
8. Descamps F.J., Martens E., and Opdenakker G. Analysis of gelatinases in complex biological fluids and tissue extracts. Lab. Invest. 82 (2002) 1607-1608
9. Doherty N.S., Poubelle P., Borgeat P., Beaver T.H., Westrich G.L., and Schrader N.L. Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2. Prostaglandins 30 (1985) 769-789
10. Doherty N.S., Griffiths R.J., Hakkinen J.P., Scampoli D.N., and Milici A.J. Post-capillary venules in the "milky spots" of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis. Inflamm. Res. 44 (1995) 169-177
11. Dvorak A.M., Dvorak H.F., and Galli S.J. Ultrastructural criteria for identification of mast cells and basophils in humans, guinea pigs, and mice. Am. Rev. Respir. Dis. 128 (1983) S49-S52
12. Fang K.C., Raymond W.W., Lazarus S.C., and Caughey G.H. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J. Clin. Invest. 97 (1996) 1589-1596
13. Fang K.C., Raymond W.W., Blount J.L., and Caughey G.H. Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J. Biol. Chem. 272 (1997) 25628-25635
14. Fang K.C., Wolters P.J., Steinhoff M., Bidgol A., Blount J.L., and Caughey G.H. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J. Immunol. 162 (1999) 5528-5535
15. Fukudome K., Fujimoto S., Sato Y., Hisanaga S., and Eto T. Peritonitis increases MMP-9 activity in peritoneal effluent from CAPD patients. Nephron 87 (2001) 35-41
16. Galli S.J., Tsai M., Wershil B.K., Tam S.Y., and Costa J.J. Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. Int. Arch. Allergy Immunol. 107 (1995) 51-53
17. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23 (2005) 749-786
18. Ikeda T., and Funaba M. Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan. Immunol. Lett. 88 (2003) 21-26
19. Kanbe N., Tanaka A., Kanbe M., Itakura A., Kurosawa M., and Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur. J. Immunol. 29 (1999) 2645-2649
20. Kohler G., and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 (1975) 495-497
21. Kolaczkowska E. Shedding light on vascular permeability during peritonitis: role of mast cell histamine versus macrophage cysteinyl leukotrienes. Inflamm. Res. 51 (2002) 519-521
22. Kolaczkowska E., Seljelid R., and Plytycz B. Critical role of mast cells in morphine-mediated impairment of zymosan-induced peritonitis in mice. Inflamm. Res. 50 (2001) 415-421
23. Kolaczkowska E., Seljelid R., and Plytycz B. Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice. J. Leukoc. Biol. 69 (2001) 33-42
24. Kolaczkowska E., Shahzidi S., Seljelid R., van Rooijen N., and Plytycz B. Early vascular permeability in murine experimental peritonitis is comediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation 26 (2002) 61-71
25. Kolaczkowska E., Chadzinska M., Scislowska-Czarnecka A., Plytycz B., Opdenakker G., and Arnold B. Gelatinase B/matrix metalloproteinase-9 contributes to cellular infiltration in a murine model of zymosan peritonitis. Immunobiol 211 (2006) 137-148
26. Kolaczkowska E., Scislowska-Czarnecka A., Chadzinska M., Plytycz B., van Rooijen N., Opdenakker G., and Arnold B. Enhanced early vascular permeability in gelatinase B (MMP-9)-deficient mice: putative contribution of COX-1-derived PGE2 of macrophage origin. J. Leukoc. Biol. 80 (2006) 125-132
27. Larsen P.H., Wells J.E., Stallcup W.B., Opdenakker G., and Yong V.W. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J. Neurosci. 23 (2003) 11127-11135
28. Levi-Schaffer F., Slovik D., Armetti L., Pickholtz D., and Touitou E. Activation and inhibition of mast cells degranulation affect their morphometric parameters. Life Sci. 66 (2000) PL283-PL290
29. Lijnen H.R., Silence J., Van Hoef B., and Collen D. Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice. Blood 91 (1998) 2045-2053
30. Mainardi C.L., Hibbs M.S., Hasty K.A., and Seyer J.M. Purification of a type V collagen degrading metalloproteinase from rabbit alveolar macrophages. Coll. Relat. Res. 4 (1984) 479-492
31. Masure S., Paemen L., Van Aelst I., Fiten P., Proost P., Billiau A., Van Damme J., and Opdenakker G. Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration. Eur. J. Biochem. 244 (1997) 21-30
32. Mullaly S.C., and Kubes P. Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis. Eur. J. Immunol. 37 (2007) 224-234
33. Murphy G., and Docherty A.J. The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7 (1992) 120-125
34. Nielsen B.S., Timshel S., Kjeldsen L., Sehested M., Pyke C., Borregaard N., and Dano K. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int. J. Cancer 65 (1996) 57-62
35. Ogata Y., Enghild J.J., and Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem. 267 (1992) 3581-3584
36. Opdenakker G., and Van Damme J. Cytokine-regulated proteases in autoimmune diseases. Immunol. Today 15 (1994) 103-107
37. Opdenakker G., Van den Steen P.E., Dubois B., Nelissen I., Van Coillie E., Masure S., Proost P., and Van Damme J. Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 69 (2001) 851-859
38. Opdenakker G., Van den Steen P.E., and Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 22 (2001) 571-579
39. Opdenakker G., Van den Steen P.E., Laureys G., Hunninck K., and Arnold B. Neutralizing antibodies in gene-defective hosts. Trends Immunol. 24 (2003) 94-100
40. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., Schroeder L., and Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA 97 (2000) 13766-13771
41. Paemen L., Martens E., Masure S., and Opdenakker G. Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity. Eur. J. Biochem. 234 (1995) 759-765
42. Parks W.C., Wilson C.L., and Lopez-Boado Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4 (2004) 617-629
43. Pruijt J.F., Verzaal P., van Os R., de Kruijf E.J., van Schie M.L., Mantovani A., Vecchi A., Lindley I.J., Willemze R., Starckx S., Opdenakker G., and Fibbe W.E. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc. Natl. Acad. Sci. USA 99 (2002) 6228-6233
44. Rao T.S., Currie J.L., Shaffer A.F., and Isakson P.C. In vivo characterization of zymosan-induced mouse peritoneal inflammation. J. Pharmacol. Exp. Ther. 269 (1994) 917-925
45. Renckens R., Roelofs J.J., Florquin S., de Vos A.F., Lijnen H.R., van't Veer C., and van der Poll T. Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J. Immunol. 176 (2006) 3735-3741
46. Ro Y., Hamada C., Io H., Hayashi K., Hirahara I., and Tomino Y. Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP-9 test kit. J. Clin. Lab. Anal. 18 (2004) 224-230
47. Sopata I., and Dancewicz A.M. Presence of a gelatin-specific proteinase and its latent form in human leucocytes. Biochim. Biophys. Acta 370 (1974) 510-523
48. Tanaka A., and Matsuda H. IgE crosslinkage of Fcepsilon receptor I induces both production and activation of matrix metalloproteinase-9 in mast cells. Cell Immunol. 228 (2004) 66-75
49. Tanaka A., Arai K., Kitamura Y., and Matsuda H. Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation. Blood 94 (1999) 2390-2395
50. Tanaka A., Yamane Y., and Matsuda H. Mast cell MMP-9 production enhanced by bacterial lipopolysaccharide. J. Vet. Med. Sci. 63 (2001) 811-813
51. Tchougounova E., Lundequist A., Fajardo I., Winberg J.O., Abrink M., and Pejler G. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 280 (2005) 9291-9296
52. Teitelbaum I. Cloudy peritoneal dialysate: it's not always infection. Contrib. Nephrol. 150 (2006) 187-194
53. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., and Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37 (2002) 375-536
54. Van Wart H.E., and Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87 (1990) 5578-5582
55. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91 (1997) 439-442